Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2017-09-01
2018-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patterns of Care and Outcomes in METAstatic Soft Tissue SARComa
NCT03977818
Study of Genetic and Cellular Immunological Parameters Predictive of Disease-free Survival in Patients With Metastatic Cancer
NCT02838381
Observational Study of Correlation Between Recurrent Basal Cell Carcinoma and Localisation
NCT04795297
Study of Pancreatic Neuroendocrine Tumors and Carcinomas in Alsace Region
NCT04134832
A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers
NCT06541652
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of primary Merkel carcinoma (topographic code C44 morphological code 8247/3)
* Diagnosis made between 1983 and 2011
* Patient residing in the Bas-Rhin at the date of diagnosis
* Patient who has given his consent for the use of his data for research purposes
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dan LIPSKER, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Strasbourg, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Dermatologie
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6840
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.